| Organism name | Passiflora incarnata |
|---|---|
| Genus | Passiflora |
| Family | Passifloraceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Passiflora incarnata |
|---|---|
| Linked NCBI taxonomy ID | 159425 |
| Linked level | species |
| Family in NCBI taxonomy | Passifloraceae |
|---|---|
| ID | 3683 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| Species | Activity |
|---|---|
| Passiflora incarnata L. | Adaptogenic |
| Passiflora incarnata L. | Analgesic |
| Passiflora incarnata L. | Analgesic |
| Passiflora incarnata L. | Antiaging |
| Passiflora incarnata L. | Antiaromatase |
| Passiflora incarnata L. | Antibacterial |
| Passiflora incarnata L. | Antiinflammatory |
| Passiflora incarnata L. | Antiinflammatory |
| Passiflora incarnata L. | Antiseptic |
| Passiflora incarnata L. | Antiseptic |
| Passiflora incarnata L. | Antispasmodic |
| Passiflora incarnata L. | Antispasmodic |
| Passiflora incarnata L. | Antistress |
| Passiflora incarnata L. | Antitussive |
| Passiflora incarnata L. | Anxiolytic |
| Passiflora incarnata L. | Anxiolytic |
| Passiflora incarnata L. | Aphrodisiac |
| Passiflora incarnata L. | Bactericide |
| Passiflora incarnata L. | Candidicide |
| Passiflora incarnata L. | Candidicide |
| Passiflora incarnata L. | Cardiotonic |
| Passiflora incarnata L. | Cardiotonic |
| Passiflora incarnata L. | CNS-Depressant |
| Passiflora incarnata L. | CNS-Depressant |
| Passiflora incarnata L. | CNS-Stimulant |
| Passiflora incarnata L. | CNS-Stimulant |
| Passiflora incarnata L. | Cyanogenic |
| Passiflora incarnata L. | Cyanogenic |
| Passiflora incarnata L. | Digestive |
| Passiflora incarnata L. | Digestive |
| Passiflora incarnata L. | Emetic |
| Passiflora incarnata L. | Emetic |
| Passiflora incarnata L. | Fungicide |
| Passiflora incarnata L. | Fungicide |
| Passiflora incarnata L. | Gram(-)-icide |
| Passiflora incarnata L. | Hematinic |
| Passiflora incarnata L. | Hematinic |
| Passiflora incarnata L. | Hypnotic |
| Passiflora incarnata L. | Hypnotic |
| Passiflora incarnata L. | Hypotensive |
| Passiflora incarnata L. | Hypotensive |
| Passiflora incarnata L. | MAOI |
| Passiflora incarnata L. | MAOI |
| Passiflora incarnata L. | Myorelaxant |
| Passiflora incarnata L. | Myorelaxant |
| Passiflora incarnata L. | Narcotic |
| Passiflora incarnata L. | Narcotic |
| Passiflora incarnata L. | Nervine |
| Passiflora incarnata L. | Respirastimulant |
| Passiflora incarnata L. | Respirostimulant |
| Passiflora incarnata L. | Sedative |
| Passiflora incarnata L. | Sedative |
| Passiflora incarnata L. | Soporific |
| Passiflora incarnata L. | Soporific |
| Passiflora incarnata L. | Spermatogenic |
| Passiflora incarnata L. | Tonic |
| Passiflora incarnata L. | Tranquilizer |
| Passiflora incarnata L. | Tranquilizer |
| Passiflora incarnata L. | Uterorelaxant |
| Passiflora incarnata L. | Uterorelaxant |
| Passiflora incarnata L. | Uterotonic |
| Passiflora incarnata L. | Uterotonic |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00006224
|
Saponarin
|
C457771
|
No. 1 | No. 15 |
|
|||
|
C00006223
|
Meloside A
/ Isovitexin 2''-O-glucoside |
No. 1 | No. 15 |
|
||||
|
C00006210
|
Meloside L
/ Isoorientin 2''-O-glucopyranoside |
No. 1 | No. 15 |
|
||||
|
C00001737
|
Harmine
|
CHEMBL269538
|
D006247
|
150 / 45 / 26 | 3 / 5 | No. 1889 | No. 4 |
|
|
C00001736
|
Harman
/ Harmane / Indoter / Locuturin / Zygofabagine |
CHEMBL12014
|
C005010
|
109 / 46 / 33 | 2 / 2 | No. 1889 | No. 4 |
|
|
C00001735
|
Harmaline
|
CHEMBL340807
|
D006246
|
101 / 52 / 45 | 6 / 4 | No. 7732 | No. 4 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001735 C00001736 C00001737 | 1 / 0 |
| Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | C00001735 C00001736 C00001737 | 1 / 1 |
| P67870 | Casein kinase II subunit beta | REG serine/threonine protein kinase family | C00001735 C00001736 C00001737 | 0 / 0 |
| P19784 | Casein kinase II subunit alpha' | Ck2 | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00001735 C00001736 C00001737 | 0 / 0 |
| Q8TDX7 | Serine/threonine-protein kinase Nek7 | Nek | C00001735 C00001736 C00001737 | 0 / 0 |
| P68400 | Casein kinase II subunit alpha | Ck2 | C00001735 C00001736 C00001737 | 0 / 0 |
| P45983 | Mitogen-activated protein kinase 8 | Jnk | C00001735 C00001736 C00001737 | 0 / 0 |
| P78396 | Cyclin-A1 | Other cytosolic protein | C00001735 C00001736 C00001737 | 0 / 0 |
| P20248 | Cyclin-A2 | Other cytosolic protein | C00001735 C00001736 C00001737 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001735 C00001736 C00001737 | 0 / 0 |
| Q15759 | Mitogen-activated protein kinase 11 | p38 | C00001735 C00001736 C00001737 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001735 C00001736 C00001737 | 0 / 0 |
| P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | C00001735 C00001736 C00001737 | 0 / 0 |
| O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | C00001735 C00001736 C00001737 | 0 / 0 |
| P41240 | Tyrosine-protein kinase CSK | Csk | C00001735 C00001736 C00001737 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001735 C00001736 C00001737 | 0 / 0 |
| P45984 | Mitogen-activated protein kinase 9 | Jnk | C00001735 C00001736 C00001737 | 0 / 0 |
| Q86V86 | Serine/threonine-protein kinase pim-3 | Pim | C00001735 C00001736 C00001737 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001735 C00001736 C00001737 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001735 C00001736 C00001737 | 0 / 0 |
| O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | C00001735 C00001736 C00001737 | 0 / 0 |
| Q8TD08 | Mitogen-activated protein kinase 15 | Mapk | C00001735 C00001736 C00001737 | 0 / 0 |
| Q8IWQ3 | Serine/threonine-protein kinase BRSK2 | CAMK serine/threonine protein kinase BRSK subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| P27448 | MAP/microtubule affinity-regulating kinase 3 | CAMK serine/threonine protein kinase MARK subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| O00418 | Eukaryotic elongation factor 2 kinase | Atypical serine/threonine protein kinase alpha subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| Q96GD4 | Aurora kinase B | Aur | C00001735 C00001736 C00001737 | 0 / 0 |
| P53778 | Mitogen-activated protein kinase 12 | p38 | C00001735 C00001736 C00001737 | 0 / 0 |
| Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | C00001735 C00001736 C00001737 | 1 / 0 |
| P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | C00001735 C00001736 C00001737 | 0 / 0 |
| Q14012 | Calcium/calmodulin-dependent protein kinase type 1 | Camk1 | C00001735 C00001736 C00001737 | 0 / 0 |
| O96017 | Serine/threonine-protein kinase Chk2 | Rad53 | C00001735 C00001736 C00001737 | 4 / 1 |
| Q05513 | Protein kinase C zeta type | Iota | C00001735 C00001736 C00001737 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001735 C00001736 C00001737 | 3 / 3 |
| P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001735 C00001736 C00001737 | 0 / 0 |
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00001735 C00001736 C00001737 | 0 / 0 |
| P48730 | Casein kinase I isoform delta | Ck1 | C00001735 C00001736 C00001737 | 1 / 0 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001735 C00001736 C00001737 | 2 / 2 |
| P23443 | Ribosomal protein S6 kinase beta-1 | p70 | C00001735 C00001736 C00001737 | 0 / 0 |
| Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9UQB9 | Aurora kinase C | Aur | C00001735 C00001736 C00001737 | 1 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9HBH9 | MAP kinase-interacting serine/threonine-protein kinase 2 | CAMK serine/threonine protein kinase MNK subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9NQU5 | Serine/threonine-protein kinase PAK 6 | STE serine/threonine protein kinase PAKB subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| Q16644 | MAP kinase-activated protein kinase 3 | CAMK serine/threonine protein kinase MAPKAPK | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9H422 | Homeodomain-interacting protein kinase 3 | CMGC dual-specificity kinase HIPK | C00001735 C00001736 C00001737 | 0 / 0 |
| Q14680 | Maternal embryonic leucine zipper kinase | Melk | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9H2X6 | Homeodomain-interacting protein kinase 2 | CMGC dual-specificity kinase HIPK | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9BUB5 | MAP kinase-interacting serine/threonine-protein kinase 1 | CAMK serine/threonine protein kinase MNK subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9HC98 | Serine/threonine-protein kinase Nek6 | Nek | C00001735 C00001736 C00001737 | 0 / 0 |
| Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001735 C00001736 C00001737 | 1 / 1 |
| Q13188 | Serine/threonine-protein kinase 3 | STE serine/threonine protein kinase MST subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| P31751 | RAC-beta serine/threonine-protein kinase | Akt | C00001735 C00001736 C00001737 | 2 / 2 |
| O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | C00001735 C00001736 C00001737 | 0 / 0 |
| Q16513 | Serine/threonine-protein kinase N2 | Pkn | C00001735 C00001736 C00001737 | 0 / 0 |
| Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00001735 C00001736 C00001737 | 0 / 0 |
| Q96RR4 | Calcium/calmodulin-dependent protein kinase kinase 2 | META serine/threonine protein kinase subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001735 C00001736 C00001737 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001735 C00001736 C00001737 | 0 / 1 |
| Q8N5S9 | Calcium/calmodulin-dependent protein kinase kinase 1 | META serine/threonine protein kinase subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| Q9P286 | Serine/threonine-protein kinase PAK 7 | STE serine/threonine protein kinase PAKB subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| P51955 | Serine/threonine-protein kinase Nek2 | Nek | C00001735 C00001736 C00001737 | 0 / 0 |
| Q96SB4 | SRSF protein kinase 1 | Srpk | C00001735 C00001736 C00001737 | 0 / 0 |
| Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | C00001735 C00001736 C00001737 | 0 / 0 |
| O43781 | Dual specificity tyrosine-phosphorylation-regulated kinase 3 | CMGC dual-specificity kinase DYRK2 | C00001735 C00001736 C00001737 | 0 / 0 |
| O96013 | Serine/threonine-protein kinase PAK 4 | STE serine/threonine protein kinase PAKB subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| O15264 | Mitogen-activated protein kinase 13 | p38 | C00001735 C00001736 C00001737 | 0 / 0 |
| P53779 | Mitogen-activated protein kinase 10 | Jnk | C00001735 C00001736 C00001737 | 0 / 1 |
| O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | C00001735 C00001736 C00001737 | 4 / 1 |
| O75116 | Rho-associated protein kinase 2 | Rock | C00001735 C00001736 C00001737 | 0 / 0 |
| Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | C00001735 C00001736 C00001737 | 0 / 0 |
| P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | C00001735 C00001736 C00001737 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001735 C00001736 C00001737 | 1 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001735 C00001736 C00001737 | 0 / 0 |
| Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | C00001735 C00001736 C00001737 | 0 / 0 |
| P51812 | Ribosomal protein S6 kinase alpha-3 | Rskb | C00001735 C00001736 C00001737 | 2 / 2 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001735 C00001737 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001736 C00001737 | 1 / 1 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001736 C00001737 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00001735 C00001736 | 1 / 2 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001735 C00001736 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001736 C00001737 | 0 / 1 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001735 C00001736 | 4 / 3 |
| P47898 | 5-hydroxytryptamine receptor 5A | Serotonin receptor | C00001735 C00001737 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001736 C00001737 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001735 C00001736 | 3 / 2 |
| O00255 | Menin | Unclassified protein | C00001735 C00001736 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001735 C00001736 | 1 / 2 |
| Q99700 | Ataxin-2 | Unclassified protein | C00001735 C00001737 | 1 / 1 |
| Q02156 | Protein kinase C epsilon type | Eta | C00001737 | 0 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001737 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001737 | 2 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001737 | 0 / 0 |
| Q8TF76 | Serine/threonine-protein kinase haspin | Haspin | C00001737 | 0 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001737 | 1 / 0 |
| P35348 | Alpha-1A adrenergic receptor | Adrenergic receptor | C00001737 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001737 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001737 | 0 / 0 |
| P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00001737 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00001735 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001737 | 2 / 0 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001736 | 0 / 0 |
| P07948 | Tyrosine-protein kinase Lyn | Src | C00001737 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00001735 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00001735 | 1 / 1 |
| Q9Y463 | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | CMGC dual-specificity kinase DYRK1 | C00001737 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001737 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001737 | 0 / 0 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001737 | 2 / 2 |
| Q9HAZ1 | Dual specificity protein kinase CLK4 | Clk | C00001737 | 0 / 0 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001735 | 1 / 0 |
| Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00001737 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001736 | 0 / 0 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001736 | 1 / 0 |
| P49761 | Dual specificity protein kinase CLK3 | Clk | C00001737 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001737 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001737 | 0 / 0 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00001737 | 1 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001737 | 1 / 1 |
| P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001737 | 0 / 0 |
| P35368 | Alpha-1B adrenergic receptor | Adrenergic receptor | C00001737 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001737 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001737 | 0 / 1 |
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00001737 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001737 | 0 / 0 |
| P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001737 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001737 | 1 / 1 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001737 | 0 / 1 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001735 | 11 / 10 |
| P49760 | Dual specificity protein kinase CLK2 | Clk | C00001737 | 0 / 0 |
| Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | C00001735 | 1 / 4 |
| P29466 | Caspase-1 | C14 | C00001735 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001735 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00001735 | 1 / 1 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001735 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001735 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001735 | 1 / 1 |
| P06746 | DNA polymerase beta | Enzyme | C00001735 | 0 / 0 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001737 | 0 / 0 |
| Q04759 | Protein kinase C theta type | Delta | C00001737 | 0 / 1 |
| P06280 | Alpha-galactosidase A | Enzyme | C00001735 | 1 / 1 |
| O94806 | Serine/threonine-protein kinase D3 | Pkd | C00001737 | 0 / 0 |
| Q05655 | Protein kinase C delta type | Delta | C00001737 | 0 / 0 |
| P05129 | Protein kinase C gamma type | Alpha | C00001737 | 1 / 1 |
| P05771 | Protein kinase C beta type | Alpha | C00001737 | 0 / 0 |
| P24723 | Protein kinase C eta type | Eta | C00001737 | 1 / 0 |
| P41743 | Protein kinase C iota type | Iota | C00001737 | 0 / 0 |
| Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001736 | 0 / 0 |
| P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001736 | 1 / 0 |
| P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001736 | 1 / 1 |
| P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001736 | 0 / 0 |
| O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001736 | 1 / 1 |
| P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001736 | 0 / 0 |
| Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001736 | 0 / 0 |
| P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001736 | 0 / 0 |
| Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001736 | 0 / 0 |
| P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001736 | 0 / 0 |
| O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001736 | 0 / 0 |
| P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001736 | 0 / 0 |
| P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001736 | 4 / 2 |
| P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001736 | 0 / 0 |
| Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001736 | 0 / 0 |
| P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001736 | 1 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001737 | 2 / 0 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001737 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001737 | 0 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001737 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001737 | 0 / 0 |
| P51946 | Cyclin-H | Other cytosolic protein | C00001737 | 0 / 0 |
| P50613 | Cyclin-dependent kinase 7 | Cdk7 | C00001737 | 0 / 0 |
| O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00001737 | 0 / 0 |
| P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00001737 | 0 / 0 |
| P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00001737 | 0 / 0 |
| Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00001737 | 0 / 0 |
| Q9NR20 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 | Enzyme | C00001737 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001736 | 2 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00001737 | 4 / 1 |
| P49759 | Dual specificity protein kinase CLK1 | Clk | C00001737 | 0 / 0 |
| Q9Y2I1 | Nischarin | Other cytosolic protein | C00001737 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001737 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001737 | 0 / 0 |
| P21918 | D(1B) dopamine receptor | Dopamine receptor | C00001737 | 1 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001737 | 2 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001737 | 1 / 0 |
| P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001737 | 0 / 0 |
| O95264 | 5-hydroxytryptamine receptor 3B | NS | C00001737 | 0 / 0 |
| O60563 | Cyclin-T1 | Other cytosolic protein | C00001737 | 0 / 0 |
| P50750 | Cyclin-dependent kinase 9 | Cdk9 | C00001737 | 0 / 0 |
| Q92698 | DNA repair and recombination protein RAD54-like | Enzyme | C00001736 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001735
C00001736
C00001737
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001735
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00001735
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001735
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001736
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00001735
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001735
|
| 1859 | DYRK1A, DYRK, DYRK1, HP86, MNB, MNBH, MRD7 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (EC:2.7.12.1) |
C00001737
|
| 4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00001737
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
| #613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #208900 | Ataxia-telangiectasia; at |
Q13315
|
| #606798 | Blepharospasm, benign essential |
P21918
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #114480 | Breast cancer |
O96017
P31749 |
| #300615 | Brunner syndrome |
P21397
|
| #615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #303600 | Coffin-lowry syndrome; cls |
P51812
|
| #114500 | Colorectal cancer; crc |
P31749
P84022 |
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P31751
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #607208 | Dravet syndrome |
P18507
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
| #612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
| #613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
| #611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
| #611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #609265 | Li-fraumeni syndrome 2; lfs2 |
O96017
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300844 | Mental retardation, x-linked 19; mrx19 |
P51812
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259500 | Osteogenic sarcoma |
O96017
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #172700 | Pick disease of brain |
P10636
|
| #176807 | Prostate cancer |
O96017
|
| #176920 | Proteus syndrome |
P31749
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #243060 | Spermatogenic failure 5; spgf5 |
Q9UQB9
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601367 | Stroke, ischemic |
P24723
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
| H00881 | Li-Fraumeni syndrome |
O96017
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H00027 | Ovarian cancer |
P31751
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P51812
(related)
Q99714 (related) |
| H00574 | Coffin-Lowry syndrome (CLS) |
P51812
(related)
|
| H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00408 | Type I diabetes mellitus |
Q04759
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
Q13315
(related)
|
| H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
| H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
| H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H01282 | Spermatogenic failure |
Q9UQB9
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D014202 | Tremor |
C00001736
C00001735 C00001737 |
| D006212 | Hallucinations |
C00001735
C00001737 |
| D056486 | Drug-Induced Liver Injury |
C00001735
C00001737 |
| D020329 | Essential Tremor |
C00001735
|
| D012640 | Seizures |
C00001736
|
| D004409 | Dyskinesia, Drug-Induced |
C00001737
|
| D010243 | Paralysis |
C00001737
|